PMC5829357_01
Trend of bilirubin (total and direct) during the course of hospitalization.
CRIHEP2018-9403934.001.jpg
PMC5829357_01_CRIHEP2018-9403934.001.jpg
fig1
Bilirubin gradually trended down to 7.3 mg/dl after days (Figure 1, trend of bilirubin).
Trend of AST/ALT/ALP during the course of hospitalization.
CRIHEP2018-9403934.002.jpg
PMC5829357_01_CRIHEP2018-9403934.002.jpg
fig2
Laboratory findings were significant for total bilirubin of 24.8 mg/dl with direct bilirubin of 18.8 mg/dl, AST of 76 IU/L (Figure 2), platelets of 28 K, and albumin of 2.7 gm/dl, and the rest of the laboratory findings were within the normal limits, including ALT, ALP (Figure 2), GGT, MCV, INR, and PT.
Liver biopsy showed focal steatosis, focal nonspecific chronic inflammation, and a nonspecific increase in the lipochrome pigment in hepatocytes.
CRIHEP2018-9403934.003.jpg
PMC5829357_01_CRIHEP2018-9403934.003.jpg
fig3
Liver biopsy (Figure 3) excluded hemochromatosis, dysplasia, or malignancy. It (Figure 3) reported focal steatosis, focal nonspecific chronic inflammation, and portal fibrosis and a nonspecific increase in the lipochrome pigment in hepatocytes.